Ischemic Conditioning for Stroke
(PLM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Stroke survivors have compromised vascular function which may contribute to secondary stroke risk, cardiovascular disease, and may limit their exercise tolerance. No studies have examined how femoral blood flow responds to both passive leg movement, a measure of microvascular function, as well as active leg contractions, a measure of the hyperemic response to exercise. Leg muscles with a reduced blood flow response to movement could be associated with decreased neuromuscular function, such as leg strength and fatigue. Preliminary data showing a single bout of ischemic conditioning may improve vascular function and muscle activation in healthy adults and individuals post-stroke. Therefore, the investigators want to examine if ischemic conditioning will also improve the blood flow response to passive leg movements as well as during single leg active contractions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
How is remote ischemic conditioning different from other stroke treatments?
Remote ischemic conditioning (RIC) is unique because it involves temporarily restricting blood flow to a limb, like using a blood pressure cuff, to protect the brain during a stroke. This noninvasive method is different from standard treatments like clot-busting drugs or surgery, as it aims to enhance the body's natural protective responses without directly targeting the stroke site.12345
What data supports the effectiveness of the treatment Ischemic Conditioning for Stroke?
Who Is on the Research Team?
Matthew Durand, PhD
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for stroke survivors aged 18-85 with residual hemiparesis from a stroke at least 6 months prior, and healthy adults aged 18-30. Participants must be able to understand instructions and communicate in English. Exclusions include severe mobility issues, recent severe COVID-19 or head trauma, other neurological disorders, heart attack within the last year, high blood pressure, pregnancy/breastfeeding, or conditions where leg compression is unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ischemic conditioning with varying cuff pressures to assess effects on leg blood flow and muscle function
Follow-up
Participants are monitored for changes in femoral blood flow and muscle function after ischemic conditioning
Post-Conditioning Assessment
Assessment of femoral blood flow response to neuromuscular fatigue task
What Are the Treatments Tested in This Trial?
Interventions
- Ischemic Conditioning
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor
Marquette University
Collaborator